Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 2, 1996, Pages 183-186

  Pepin J ^a,c   Khonde, N ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Zone de Santé Rurale de Nioki   (Congo)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Relapse; Suramin plus pentamidine; Treatment; Trypanosoma b. gambiense; Trypanosomiasis; Zaire

Indexed keywords

DIMINAZENE ACETURATE; PENTAMIDINE MESYLATE; SURAMIN;

ADOLESCENT; ADULT; AFRICAN TRYPANOSOMIASIS; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHILD; DEMOCRATIC REPUBLIC CONGO; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG COST; DRUG PENETRATION; FEMALE; HUMAN; HUMAN CELL; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; RELAPSE; RISK; TREATMENT FAILURE; TRYPANOSOMA;

EID: 0029874460     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90132-7     Document Type: Article

References (29)

1. Apted, F. I. C. (1970). Treatment of human trypanosomiasis. In: The African Trypanosomiases, Mulligan, H. W. & Potts, W. H. (editors). London: George Allen and Unwin, pp. 684-710.
2. Apted, F. I. C. (1980). Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the eastern hemisphere. Pharmacology and Therapeutics, 11, 391-413.
3. Bronner, U. (1994). Pharmacokinetcs of pentamidine. Focus on treatment of Trypanosoma gambiense sleeping sickness. PhD Thesis, Karolinska Institute, Stockholm.
4. Bronner, U., Doua, F., Ericsson, O., Gustafsson, L. L., Miézan, T. W., Rais, M. & Rombo, L. (1991). Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 608-611.
5. Cattand, P., Miézan, B. T. & De Raadt, P. (1988). Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bulletin of the World Health Organization, 66, 83-86.
6. Chesterman, C. C. (1924). The therapeutic effect of "Bayer 205" in trypanosomiasis of the central nervous system. Transactions of the Royal Society of Tropical Medicine and Hygiene, 18, 311-317.
7. Collins, J. M., Klecker, R. W., Yarchoan, R., Lane, H. C., Fauci, A. S., Redfield, R. R., Broder, S. & Myers, C. E. (1986). Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. Journal of Clinical Pharmacology, 26, 22-26.
8. Dutertre, J. & Labusquière, R. (1966). La thérapeutique de la trypanosomiase. Médecine Tropicale, 26, 342-356.
9. Goa, K. L. & Campoli-Richards, D. M. (1987). Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs, 33, 242-258.
10. Guimaraes, J. L. & Lourie, E. M. (1951). The inhibition of some pharmacological action of pentamidine by suramin. British Journal of Pharmacology, 6, 514-530.
11. Hawking, F. (1940). Concentration of Bayer 205 (germanin) in human blood and cerebrospinal fluid after treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 34, 37-52.
12. Hutchinson, M. P. & Watson, H. J. C. (1962). Berenil in the treatment of Trypanosoma gambiense infection in man. Transactions of the Royal Society of Tropical Medicine and Hygiene, 56, 227-230.
13. Jonchère, H. (1951). Traitement par les diamidines de la phase lymphatico-sanguine de la trypanosomaise humaine en Afrique Occidentale Française. Bulletin de la Société de Pathologie Exotique et de ses Filiales, 44, 603-625.
14. Kayembe, D. & Wéry, M. (1972). Observations sur la sensibilité aux diamidines de souches de Trypanosoma gambiense récemment isolées en République du Zaire. Annales de la Société Belge de Médecine Tropicale, 52, 1-8.
15. Keevill, A. J. (1934). Subsequent histories of six cases of Trypanosoma rhodesiense infection treated with "Bayer 205" or "Fourneau 309". Transactions of the Royal Society of Tropical Medicine and Hygiene, 28, 101-102.
16. Lawson, T. L. (1942). Trypanosomiasis treated with pentamidine. Lancet, ii, 480-483.
17. Le Rouzic, (1949). Traitement curatif par pentamidine et lomidine. Bulletin Médicale de l'Afrique Occidentale Française, 47, numéro spécial, 47-51.
18. Miézan, T. W., Bronner, U., Doua, F., Cattand, P. & Rombo, L. (1994). Long term exposure of Trypanosoma brucei gambiense to pentamidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 332-333.
19. Neujean, G. & Evens, F. (1958). Diagnostic et traitement de la maladie du sommeil à T. gambiense. Bilan de 10 ans d'activités du centre de traitement de Léopoldville. Académie Royale des Sciences Coloniales: Classe des Sciences Naturelles et Médicales. Mémoires in-8°, 7, Fascicule 2.
20. Pépin, J. & Milord, F. (1994). The treatment of human African trypanosomiasis. Advances in Parasitology, 33, 1-47.
21. Pépin, J., Milord, F., Khonde, A. N., Niyonsenga, T., Loko, L., Mpia, B. & De Wals, P. (1995). Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 92-97.
22. Raseroka, B. H. & Ormerod, W. E. (1986). The trypanocidal effect of drugs in different parts of the brain. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80, 634-641.
23. Ruppol, J. F. & Burke, J. (1977). Follow-up des traitements contre la trypanosomiase expérimentés à Kimpangu (République du Zaire). Annales de la Société Belge de Médecine Tropicale, 57, 481-494.
24. Sands, M., Kron, M. A. & Brown, R. B. (1985). Pentamidine: a review. Reviews of Infectious Diseases, 7, 625-634.
25. Saunders, G. F. T., Holden, J. R. & Hughes, M. H. (1944). Second report on the treatment of trypanosomiasis by pentamidine. Annals of Tropical Medicine and Parasitology, 38, 159-168.
26. Wellde, B. T., Chumo, D. A., Reardon, M. J., Abinya, A., Wanyama, L., Dola, S., Mbwabi, D., Smith, D. H. & Siongok, T. A. (1989). Treatment of Rhodesian sleeping sickness in Kenya. Annals of Tropical Medicine and Parasitology, 83, supplement 1, 99-109.
27. WHO (1986). Epidemiology and Control of African Trypanosomiasis. Report of a WHO Expert Committee. Geneva: World Health Organization, Technical Report Series, no. 739.
28. WHO (1994). Sleeping sickness on the boil in Zaire. TDR News, no. 46, 6.
29. Woo, P. T. K. (1970). The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Tropica, 27, 384-386.